2 Aug 2013 14:55
2 August 2013
Legendary Investments Plc
("Legendary")
Investee Company Update - Medgold Resources Corp. ("Medgold") Awarded the Boticas Exploration Licence in Northern Portugal
Legendary, proactive investment company, is pleased to report that its investee company, Medgold Resources Corp. (TSX-V: MED), the European focused gold exploration company, has been awarded the Boticas exploration licence in Northern Portugal by the Direcao-Geral de Energia e Geologia of Portugal.
Zafar Karim, Executive Chairman of Legendary commented:
"We're pleased that the Boticas licence has been awarded to Medgold. Medgold now plans to fast-track to resource definition and explore the wider licence area where there are several untested gold anomalies."
Further details are available at:
http://www.medgoldresources.com/images/content/Aug1.pdf
For further information, please contact:
Contact: | ||
Legendary Investments Plc | Zafar Karim / Thomas Reuner
| 020 8201 3536 |
Grant Thornton UK LLP
| Colin Aaronson/ Melanie Frean / Jen Clarke
| 020 7383 5100 |
SI Capital
| Nick Emerson/ Andrew Thacker | 01483 413500 |
Newgate Threadneedle | Caroline Evans-Jones | 020 7653 9850
|
About Legendary Investments Plc
Legendary is a proactive investment company that focuses on making investments in and assisting companies which exhibit the potential to generate returns of many multiples through capital appreciation. Typically, Legendary invests in small companies where there are clear catalysts for value appreciation and the companies are operating in sectors exhibiting long term growth. Examples of such sectors include technology, energy, natural resources and mining. Legendary is incorporated in the UK, which is its principal country of operation.